Drug-class overview:@0.657199:0.039086:0.902803:0.039086:0.902803:0.019651:0.657199:0.019651:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
37:@0.950592:0.038665:0.976698:0.038665:0.976698:0.018632:0.950592:0.018632:0.000000:0.000000
Drug-class overview:@0.981851:0.292741:0.981851:0.109337:0.953582:0.109337:0.953582:0.292741:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
MIMS ConCISe GuIde to CardIovaSCular, MetabolIC and endoCrIne dISeaSeS :@0.216640:0.974259:0.820834:0.974259:0.820834:0.960936:0.216640:0.960936:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.820834:0.974259:0.824580:0.974259:0.824580:0.960936:0.820834:0.960936:0.000000
VOLUME 1:@0.824751:0.974259:0.906065:0.974259:0.906065:0.959690:0.824751:0.959690:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.096970:0.096324:0.105783:0.096324:0.105783:0.081640:0.096970:0.081640:0.000000
 Maintenance dose ranges from 2-10 mg daily   :@0.105783:0.096840:0.480028:0.096840:0.480028:0.081852:0.105783:0.081852:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.467001:0.096324:0.475814:0.096324:0.475814:0.081640:0.467001:0.081640:0.000000
Give dose at same time each day:@0.096970:0.111816:0.348660:0.111816:0.348660:0.096827:0.096970:0.096827:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Contraindications::@0.096970:0.131263:0.254757:0.131263:0.254757:0.114872:0.096970:0.114872:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
20:@0.254755:0.125480:0.267208:0.125480:0.267208:0.115924:0.254755:0.115924:0.000000:0.000000
Haemorrhagic  states    Peptic  ulcers  and  other :@0.096970:0.146247:0.479951:0.146247:0.479951:0.131258:0.096970:0.131258:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.268381:0.145731:0.277194:0.145731:0.277194:0.131046:0.268381:0.131046:0.000000
GI diseases involved in bleeding   Conditions :@0.096989:0.161222:0.479990:0.161222:0.479990:0.146233:0.096989:0.146233:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.373618:0.160706:0.382431:0.160706:0.382431:0.146022:0.373618:0.146022:0.000000
involving bleeding from respiratory or genito-:@0.096989:0.176197:0.475756:0.176197:0.475756:0.161209:0.096989:0.161209:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
urinary tract   Severe wounds, including surgical :@0.096989:0.191173:0.479970:0.191173:0.479970:0.176184:0.096989:0.176184:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.197069:0.190657:0.205882:0.190657:0.205882:0.175973:0.197069:0.175973:0.000000
wounds   Infective endocarditis   Impaired :@0.096989:0.206148:0.479990:0.206148:0.479990:0.191160:0.096989:0.191160:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.173169:0.205632:0.181982:0.205632:0.181982:0.190948:0.173169:0.190948:0.000000
:@0.384182:0.205632:0.392995:0.205632:0.392995:0.190948:0.384182:0.190948:0.000000
renal or hepatic function :@0.096989:0.221124:0.331169:0.221124:0.331169:0.206135:0.096989:0.206135:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.344850:0.220608:0.353663:0.220608:0.353663:0.205923:0.344850:0.205923:0.000000
 Hypertension :@0.353663:0.221124:0.479990:0.221124:0.479990:0.206135:0.353663:0.206135:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.475776:0.221124:0.479990:0.221124:0.479990:0.206135:0.475776:0.206135:0.000000
:@0.096989:0.235583:0.105802:0.235583:0.105802:0.220899:0.096989:0.220899:0.000000
 Cerebrovascular haemorrhage :@0.105802:0.236099:0.372559:0.236099:0.372559:0.221111:0.105802:0.221111:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.385625:0.235583:0.394438:0.235583:0.394438:0.220899:0.385625:0.220899:0.000000
 Cerebral :@0.394419:0.236099:0.480009:0.236099:0.480009:0.221111:0.394419:0.221111:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
or aortic aneurysm   Pericarditis   Pericardial :@0.097008:0.251075:0.480028:0.251075:0.480028:0.236086:0.097008:0.236086:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.264975:0.250559:0.273788:0.250559:0.273788:0.235874:0.264975:0.235874:0.000000
:@0.377889:0.250559:0.386702:0.250559:0.386702:0.235874:0.377889:0.235874:0.000000
effusion   recent or contemplated neurological :@0.097008:0.266050:0.479990:0.266050:0.479990:0.251061:0.097008:0.251061:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.165588:0.265534:0.174401:0.265534:0.174401:0.250850:0.165588:0.250850:0.000000
or ophthalmic surgery   Polyarthritis   vitamin C :@0.097008:0.281330:0.480009:0.281330:0.480009:0.266341:0.097008:0.266341:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.276270:0.280814:0.285083:0.280814:0.285083:0.266129:0.276270:0.266129:0.000000
:@0.386722:0.280814:0.395535:0.280814:0.395535:0.266129:0.386722:0.266129:0.000000
deficiency   Major regional blocking anaesthesia :@0.097008:0.296609:0.480009:0.296609:0.480009:0.281621:0.097008:0.281621:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.181405:0.296093:0.190218:0.296093:0.190218:0.281409:0.181405:0.281409:0.000000
:@0.097008:0.311373:0.105821:0.311373:0.105821:0.296689:0.097008:0.296689:0.000000
  Inadequate  laboratory  facilities  or  poor :@0.105821:0.311889:0.479970:0.311889:0.479970:0.296900:0.105821:0.296900:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
patient co-operation   Pregnancy and lactation  :@0.097008:0.327169:0.480009:0.327169:0.480009:0.312180:0.097008:0.312180:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.267149:0.326653:0.275962:0.326653:0.275962:0.311968:0.267149:0.311968:0.000000
:@0.097008:0.341932:0.105821:0.341932:0.105821:0.327248:0.097008:0.327248:0.000000
 threatening abortion   nSaIds:@0.105821:0.342448:0.346120:0.342448:0.346120:0.327460:0.105821:0.327460:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.276944:0.341932:0.285757:0.341932:0.285757:0.327248:0.276944:0.327248:0.000000
Side effects::@0.097027:0.362186:0.200244:0.362186:0.200244:0.345795:0.097027:0.345795:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
20:@0.200184:0.356433:0.212637:0.356433:0.212637:0.346877:0.200184:0.346877:0.000000:0.000000
Haemorrhage   Skin necrosis   Purple toe :@0.096970:0.377494:0.479951:0.377494:0.479951:0.362505:0.096970:0.362505:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.217908:0.376978:0.226721:0.376978:0.226721:0.362293:0.217908:0.362293:0.000000
:@0.363631:0.376978:0.372444:0.376978:0.372444:0.362293:0.363631:0.362293:0.000000
syndrome    alopecia   Fever    nausea and :@0.096970:0.392773:0.479970:0.392773:0.479970:0.377785:0.096970:0.377785:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.185773:0.392257:0.194586:0.392257:0.194586:0.377573:0.185773:0.377573:0.000000
:@0.284621:0.392257:0.293434:0.392257:0.293434:0.377573:0.284621:0.377573:0.000000
:@0.357800:0.392257:0.366613:0.392257:0.366613:0.377573:0.357800:0.377573:0.000000
vomiting   diarrhoea   Hypersensitivity and skin :@0.096970:0.408053:0.479990:0.408053:0.479990:0.393064:0.096970:0.393064:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.172130:0.407537:0.180943:0.407537:0.180943:0.392853:0.172130:0.392853:0.000000
:@0.268073:0.407537:0.276886:0.407537:0.276886:0.392853:0.268073:0.392853:0.000000
reactions:@0.096970:0.423333:0.166993:0.423333:0.166993:0.408344:0.096970:0.408344:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Special precautions:  :@0.096970:0.443071:0.285737:0.443058:0.285737:0.426667:0.096970:0.426680:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
20:@0.269398:0.437273:0.281851:0.437273:0.281851:0.427717:0.269398:0.427717:0.000000:0.000000
no  abrupt  cessation    elderly    vitamin  K :@0.096969:0.458338:0.479951:0.458338:0.479951:0.443349:0.096969:0.443349:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.284294:0.457822:0.293107:0.457822:0.293107:0.443137:0.284294:0.443137:0.000000
:@0.371962:0.457822:0.380775:0.457822:0.380775:0.443137:0.371962:0.443137:0.000000
deficiency :@0.096950:0.473617:0.179942:0.473617:0.179942:0.458629:0.096950:0.458629:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.199570:0.473101:0.208383:0.473101:0.208383:0.458417:0.199570:0.458417:0.000000
Hyperthyroidism:@0.232243:0.473617:0.360917:0.473617:0.360917:0.458629:0.232243:0.458629:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.384778:0.473101:0.393591:0.473101:0.393591:0.458417:0.384778:0.458417:0.000000
regular:@0.417432:0.473617:0.475756:0.473617:0.475756:0.458629:0.417432:0.458629:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
prothrombin time determination   Close liaison :@0.096969:0.488897:0.479970:0.488897:0.479970:0.473908:0.096969:0.473908:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.362399:0.488381:0.371212:0.488381:0.371212:0.473697:0.362399:0.473697:0.000000
between doctors in patients undergoing surgery :@0.096969:0.504177:0.480008:0.504177:0.480008:0.489188:0.096969:0.489188:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
or dental procedures :@0.096969:0.519456:0.286969:0.519456:0.286969:0.504468:0.096969:0.504468:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.299803:0.518940:0.308616:0.518940:0.308616:0.504256:0.299803:0.504256:0.000000
 Prolonged dietary :@0.308597:0.519456:0.479989:0.519456:0.479989:0.504468:0.308597:0.504468:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
deficiencies    Infective  disorders    Intestinal :@0.096969:0.534736:0.479970:0.534736:0.479970:0.519747:0.096969:0.519747:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.200474:0.534220:0.209287:0.534220:0.209287:0.519536:0.200474:0.519536:0.000000
:@0.383816:0.534220:0.392629:0.534220:0.392629:0.519536:0.383816:0.519536:0.000000
flora  disturbances    Sprue    antibiotic  therapy  :@0.096969:0.550016:0.479989:0.550016:0.479989:0.535027:0.096969:0.535027:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.246040:0.549500:0.254853:0.549500:0.254853:0.534815:0.246040:0.534815:0.000000
:@0.316313:0.549500:0.325126:0.549500:0.325126:0.534815:0.316313:0.534815:0.000000
:@0.096988:0.564779:0.105801:0.564779:0.105801:0.550095:0.096988:0.550095:0.000000
 Polycythaemia vera   vasculitis   Severe diabetes :@0.105801:0.565295:0.479989:0.565295:0.479989:0.550307:0.105801:0.550307:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.259933:0.564779:0.268746:0.564779:0.268746:0.550095:0.259933:0.550095:0.000000
:@0.343811:0.564779:0.352624:0.564779:0.352624:0.550095:0.343811:0.550095:0.000000
:@0.097008:0.580059:0.105821:0.580059:0.105821:0.565375:0.097008:0.565375:0.000000
  allergic  or  anaphylactic  disorders   Good :@0.105821:0.580575:0.480047:0.580575:0.480047:0.565586:0.105821:0.565586:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.410986:0.580059:0.419799:0.580059:0.419799:0.565375:0.410986:0.565375:0.000000
patient instructions   Possible prothrombin time :@0.097027:0.595855:0.480028:0.595855:0.480028:0.580866:0.097027:0.580866:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.253525:0.595339:0.262338:0.595339:0.262338:0.580654:0.253525:0.580654:0.000000
increased in carcinoma and decreased in diabetes :@0.097027:0.611134:0.479989:0.611134:0.479989:0.596146:0.097027:0.596146:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
mellitus   Collagen disorders   CHF   diarrhoea :@0.097027:0.626414:0.480028:0.626414:0.480028:0.611425:0.097027:0.611425:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.164241:0.625898:0.173054:0.625898:0.173054:0.611214:0.164241:0.611214:0.000000
:@0.330976:0.625898:0.339789:0.625898:0.339789:0.611214:0.330976:0.611214:0.000000
:@0.384951:0.625898:0.393764:0.625898:0.393764:0.611214:0.384951:0.611214:0.000000
:@0.097027:0.641178:0.105840:0.641178:0.105840:0.626493:0.097027:0.626493:0.000000
  elevated temperature   Hepatic disorders :@0.105840:0.641694:0.480047:0.641694:0.480047:0.626705:0.105840:0.626705:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.309636:0.641178:0.318449:0.641178:0.318449:0.626493:0.309636:0.626493:0.000000
 :@0.475833:0.641694:0.480047:0.641694:0.480047:0.626705:0.475833:0.626705:0.000000
:@0.097046:0.656458:0.105859:0.656458:0.105859:0.641773:0.097046:0.641773:0.000000
 Infective hepatitis   Jaundice   Poor nutritional :@0.105859:0.656973:0.480066:0.656973:0.480066:0.641985:0.105859:0.641985:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.253487:0.656458:0.262300:0.656458:0.262300:0.641773:0.253487:0.641773:0.000000
:@0.341348:0.656458:0.350161:0.656458:0.350161:0.641773:0.341348:0.641773:0.000000
state   oedema   Hereditary resistance to warfarin :@0.097065:0.672253:0.480085:0.672253:0.480085:0.657265:0.097065:0.657265:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.137282:0.671737:0.146095:0.671737:0.146095:0.657053:0.137282:0.657053:0.000000
:@0.219139:0.671737:0.227952:0.671737:0.227952:0.657053:0.219139:0.657053:0.000000
therapy   Hypothyroidism   Hyperlipaemia:@0.097085:0.687533:0.425918:0.687533:0.425918:0.672544:0.097085:0.672544:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.160296:0.687017:0.169109:0.687017:0.169109:0.672333:0.160296:0.672333:0.000000
:@0.300939:0.687017:0.309752:0.687017:0.309752:0.672333:0.300939:0.672333:0.000000
Drug interactions::@0.097085:0.707271:0.252044:0.707271:0.252044:0.690880:0.097085:0.690880:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
20,23:@0.251927:0.701424:0.279748:0.701424:0.279748:0.691868:0.251927:0.691868:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.279748:0.707208:0.283635:0.707208:0.283635:0.690817:0.279748:0.690817:0.000000
agents that enhance the anticoagulant effect: :@0.096964:0.722488:0.479965:0.722488:0.479965:0.707499:0.096964:0.707499:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Sulphonamides   Sulphonylurea-type antidiabetic :@0.096964:0.737768:0.479984:0.737768:0.479984:0.722779:0.096964:0.722779:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.219807:0.737252:0.228621:0.737252:0.228621:0.722567:0.219807:0.722567:0.000000
agents   Clofibrate   Cimetidine   Pyrazolones, :@0.096983:0.753047:0.480003:0.753047:0.480003:0.738059:0.096983:0.738059:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.156750:0.752532:0.165563:0.752532:0.165563:0.737847:0.156750:0.737847:0.000000
:@0.255945:0.752532:0.264758:0.752532:0.264758:0.737847:0.255945:0.737847:0.000000
:@0.364530:0.752532:0.373343:0.752532:0.373343:0.737847:0.364530:0.737847:0.000000
aspirin and other  nSaIds    anabolic steroids  :@0.097002:0.768327:0.480003:0.768327:0.480003:0.753339:0.097002:0.753339:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.317905:0.767811:0.326718:0.767811:0.326718:0.753127:0.317905:0.753127:0.000000
:@0.097002:0.783091:0.105815:0.783091:0.105815:0.768407:0.097002:0.768407:0.000000
 Sulphinpyrazone   thyroid hormone   disulfiram :@0.105815:0.783607:0.480023:0.783607:0.480023:0.768618:0.105815:0.768618:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.240782:0.783091:0.249595:0.783091:0.249595:0.768407:0.240782:0.768407:0.000000
:@0.386774:0.783091:0.395587:0.783091:0.395587:0.768407:0.386774:0.768407:0.000000
and amiodarone :@0.097022:0.798887:0.241686:0.798887:0.241686:0.783898:0.097022:0.783898:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.255098:0.798371:0.263911:0.798371:0.263911:0.783686:0.255098:0.783686:0.000000
  allopurinol, :@0.263892:0.798887:0.373824:0.798887:0.373824:0.783898:0.263892:0.783898:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.387236:0.798371:0.396049:0.798371:0.396049:0.783686:0.387236:0.783686:0.000000
  danazol :@0.396029:0.798887:0.480023:0.798887:0.480023:0.783898:0.396029:0.783898:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.475808:0.798887:0.480023:0.798887:0.480023:0.783898:0.475808:0.783898:0.000000
:@0.097022:0.813650:0.105835:0.813650:0.105835:0.798966:0.097022:0.798966:0.000000
 diazoxide   Metronidazole   aminoglycosides :@0.105835:0.814166:0.480023:0.814166:0.480023:0.799178:0.105835:0.799178:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.194812:0.813650:0.203625:0.813650:0.203625:0.798966:0.194812:0.798966:0.000000
:@0.328527:0.813650:0.337340:0.813650:0.337340:0.798966:0.328527:0.798966:0.000000
 :@0.475808:0.814166:0.480023:0.814166:0.480023:0.799178:0.475808:0.799178:0.000000
:@0.097022:0.828930:0.105835:0.828930:0.105835:0.814246:0.097022:0.814246:0.000000
 alcohol   Miconazole   triclofos   Chloral hydrate :@0.105835:0.829446:0.480061:0.829446:0.480061:0.814457:0.105835:0.814457:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.170008:0.828930:0.178821:0.828930:0.178821:0.814246:0.170008:0.814246:0.000000
:@0.272609:0.828930:0.281422:0.828930:0.281422:0.814246:0.272609:0.814246:0.000000
:@0.349059:0.828930:0.357872:0.828930:0.357872:0.814246:0.349059:0.814246:0.000000
:@0.097041:0.844210:0.105854:0.844210:0.105854:0.829525:0.097041:0.829525:0.000000
 Chloramphenicol   Phenytoin    erythromycin  :@0.105854:0.844726:0.480061:0.844726:0.480061:0.829737:0.105854:0.829737:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.254521:0.844210:0.263334:0.844210:0.263334:0.829525:0.254521:0.829525:0.000000
:@0.356871:0.844210:0.365684:0.844210:0.365684:0.829525:0.356871:0.829525:0.000000
:@0.097060:0.859489:0.105873:0.859489:0.105873:0.844805:0.097060:0.844805:0.000000
 Quinidine    dextropropoxyphene   vitamin  e :@0.105873:0.860005:0.480061:0.860005:0.480061:0.845017:0.105873:0.845017:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.196197:0.859489:0.205010:0.859489:0.205010:0.844805:0.196197:0.844805:0.000000
:@0.385639:0.859489:0.394452:0.859489:0.394452:0.844805:0.385639:0.844805:0.000000
 :@0.475847:0.860005:0.480061:0.860005:0.480061:0.845017:0.475847:0.845017:0.000000
:@0.097060:0.874769:0.105873:0.874769:0.105873:0.860085:0.097060:0.860085:0.000000
 Glucagon :@0.105873:0.875285:0.188943:0.875285:0.188943:0.860296:0.105873:0.860296:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
agents that diminish the anticoagulant effect: :@0.115244:0.890565:0.480100:0.890565:0.480100:0.875576:0.115244:0.875576:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.475885:0.890565:0.480100:0.890565:0.480100:0.875576:0.475885:0.875576:0.000000
barbiturates :@0.097060:0.905844:0.193118:0.905844:0.193118:0.890856:0.097060:0.890856:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.205857:0.905328:0.214670:0.905328:0.214670:0.890644:0.205857:0.890644:0.000000
  rifampicin and glutethimide :@0.214670:0.905844:0.480100:0.905844:0.480100:0.890856:0.214670:0.890856:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.475866:0.905844:0.480080:0.905844:0.480080:0.890856:0.475866:0.890856:0.000000
:@0.097079:0.920608:0.105892:0.920608:0.105892:0.905924:0.097079:0.905924:0.000000
  oestrogens   Carbamazepine   Griseofulvin :@0.105892:0.921124:0.480100:0.921124:0.480100:0.906135:0.105892:0.906135:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.215343:0.920608:0.224156:0.920608:0.224156:0.905924:0.215343:0.905924:0.000000
:@0.365646:0.920608:0.374459:0.920608:0.374459:0.905924:0.365646:0.905924:0.000000
 :@0.475885:0.921124:0.480100:0.921124:0.480100:0.906135:0.475885:0.906135:0.000000
:@0.097099:0.936179:0.105912:0.936179:0.105912:0.921494:0.097099:0.921494:0.000000
 Glucocorticosteroids   Cholestyramine:@0.105912:0.936695:0.406536:0.936695:0.406536:0.921706:0.105912:0.921706:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.272955:0.936179:0.281768:0.936179:0.281768:0.921494:0.272955:0.921494:0.000000
REfEREnCES:@0.524569:0.096616:0.637214:0.096616:0.637214:0.080225:0.524569:0.080225:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
1.   alprostadil [database on the Internet]. 2012 [cited :@0.524242:0.110576:0.906798:0.110576:0.906798:0.097252:0.524242:0.097252:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
october 7, 2012].  available from: http://www.:@0.554551:0.124804:0.903035:0.124804:0.903035:0.111481:0.554551:0.111481:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
drugbank.ca/drugs/db00770:@0.554551:0.139033:0.752175:0.139033:0.752175:0.125710:0.554551:0.125710:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
2.   alprostadil [database on the Internet]. 2007 [cited :@0.524242:0.153262:0.906798:0.153262:0.906798:0.139939:0.524242:0.139939:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
october 16, 2012]. available from: http://drugsarea.:@0.554551:0.167491:0.903035:0.167491:0.903035:0.154167:0.554551:0.154167:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
com/dets-drugs/alprostadilpd.html:@0.554551:0.181719:0.800991:0.181719:0.800991:0.168396:0.554551:0.168396:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
3.   Snyman Jr, ed. other vasodilators. :@0.524242:0.195948:0.792541:0.195948:0.792541:0.182625:0.524242:0.182625:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Monthly Index of :@0.793191:0.195948:0.906114:0.195948:0.906114:0.182860:0.793191:0.182860:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Medical Specialities.:@0.554551:0.210177:0.683073:0.210177:0.683073:0.197089:0.554551:0.197089:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 2011;51(2):148.:@0.683073:0.210177:0.788282:0.210177:0.788282:0.196853:0.683073:0.196853:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
4.   Wilson  rF,  White CW. Intracoronary papaverine: :@0.524242:0.224405:0.906781:0.224405:0.906781:0.211082:0.524242:0.211082:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
an ideal coronary vasodilator for studies of :@0.554551:0.238634:0.906747:0.238634:0.906747:0.225311:0.554551:0.225311:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
the  coronary  circulation  in  conscious  humans. :@0.554551:0.252863:0.906747:0.252863:0.906747:0.239539:0.554551:0.239539:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Circulation. :@0.554551:0.267091:0.632017:0.267091:0.632017:0.254003:0.554551:0.254003:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
1986;73(3):444-51.:@0.632017:0.267091:0.755271:0.267091:0.755271:0.253768:0.632017:0.253768:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
5.   Papaverine [database on the Internet]. 2012 [cited :@0.524242:0.281320:0.906730:0.281320:0.906730:0.267997:0.524242:0.267997:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
october 7, 2012].  available from: http://www.:@0.554551:0.295549:0.903035:0.295549:0.903035:0.282226:0.554551:0.282226:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
drugbank.ca/drugs/db01113:@0.554551:0.309778:0.752175:0.309778:0.752175:0.296454:0.554551:0.296454:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
6.   Jeremy JY,  ballard Sa,  naylor  aM, Miller MaW, :@0.524242:0.324006:0.906781:0.324006:0.906781:0.310683:0.524242:0.310683:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
angelini Gd.  effects of sildenafil, a type-5 cGMP :@0.554551:0.338235:0.906781:0.338235:0.906781:0.324912:0.554551:0.324912:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
phosphodiesterase inhibitor, and papaverine on :@0.554551:0.352464:0.906798:0.352464:0.906798:0.339140:0.554551:0.339140:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
cyclic GMP and cyclic  aMP levels in the rabbit :@0.554551:0.366692:0.906781:0.366692:0.906781:0.353369:0.554551:0.353369:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
corpus cavernosum in vitro. :@0.554551:0.380921:0.772255:0.380921:0.772255:0.367598:0.554551:0.367598:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
British  Journal  of :@0.780876:0.380921:0.906080:0.380921:0.906080:0.367833:0.780876:0.367833:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Urology.:@0.554551:0.395150:0.608242:0.395150:0.608242:0.382062:0.554551:0.382062:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 1997;79(6):958-63.:@0.608242:0.395150:0.735241:0.395150:0.735241:0.381827:0.608242:0.381827:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
7.   tang  lM, Cheng Jt,  tong  YC. Inhibitory effect of :@0.524242:0.409378:0.906815:0.409378:0.906815:0.396055:0.524242:0.396055:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
buflomedil on prostate α1a adrenoceptor in the :@0.554551:0.423607:0.906815:0.423607:0.906815:0.410284:0.554551:0.410284:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Wistar rat. :@0.554551:0.437836:0.625038:0.437836:0.625038:0.424513:0.554551:0.424513:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Neuroscience Letters.:@0.625038:0.437836:0.759307:0.437836:0.759307:0.424748:0.625038:0.424748:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 2004;367(2):224-7.:@0.759307:0.437836:0.886307:0.437836:0.886307:0.424513:0.759307:0.424513:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
8.   daum PS,  bowers Jr  Wd,  tejada J, Morehouse  d, :@0.524242:0.452065:0.906781:0.452065:0.906781:0.438741:0.524242:0.438741:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Hamlet MP.  an evaluation of the ability of the :@0.554551:0.466293:0.906815:0.466293:0.906815:0.452970:0.554551:0.452970:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
peripheral vasodilator buflomedil to improve :@0.554551:0.480522:0.906781:0.480522:0.906781:0.467199:0.554551:0.467199:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
vascular patency after acute frostbite. :@0.554551:0.494751:0.820336:0.494751:0.820336:0.481427:0.554551:0.481427:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Cryobiology.:@0.822439:0.494751:0.903035:0.494751:0.903035:0.481663:0.822439:0.481663:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.903035:0.494751:0.906781:0.494751:0.906781:0.481427:0.903035:0.481427:0.000000
1989;26(1):85-92.:@0.554551:0.508979:0.669458:0.508979:0.669458:0.495656:0.554551:0.495656:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
9.   Moriau  M,  lavenne-Pardonge  e,  Crasborn  l,  von :@0.524242:0.523208:0.906764:0.523208:0.906764:0.509885:0.524242:0.509885:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Frenckell r, Col-debeys C. the treatment of severe or :@0.554551:0.537437:0.906798:0.537437:0.906798:0.524114:0.554551:0.524114:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
recurrent deep venous thrombosis: beneficial effect :@0.554568:0.551665:0.906798:0.551665:0.906798:0.538342:0.554568:0.538342:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
of the co-administration of antiplatelet agents with :@0.554568:0.565894:0.906781:0.565894:0.906781:0.552571:0.554568:0.552571:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
or without rheological effects, and anticoagulants. :@0.554568:0.580123:0.906764:0.580123:0.906764:0.566800:0.554568:0.566800:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Thrombosis Research.:@0.554568:0.594352:0.694482:0.594352:0.694482:0.581264:0.554568:0.581264:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 1995;78(6):469-82.:@0.694482:0.594352:0.821482:0.594352:0.821482:0.581028:0.694482:0.581028:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
10.   Core Safety Profile buflomedil Hydrochloride.:@0.524259:0.608580:0.859316:0.608580:0.859316:0.595257:0.524259:0.595257:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
11.   Pang CCY. autonomic control of the venous system :@0.524259:0.622809:0.906815:0.622809:0.906815:0.609486:0.524259:0.609486:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
in health and disease: effects of drugs. :@0.554568:0.637038:0.808670:0.637038:0.808670:0.623714:0.554568:0.623714:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Pharmacology  :@0.807388:0.637038:0.906131:0.637038:0.906131:0.623950:0.807388:0.623950:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
and Therapeutics.:@0.554568:0.651266:0.669355:0.651266:0.669355:0.638178:0.554568:0.638178:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 2001;90(2-3):179-230.:@0.669355:0.651266:0.818146:0.651266:0.818146:0.637943:0.669355:0.637943:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
12.   räsänen J, alahuhta S, Kangas-Saarela t, Jouppila r, :@0.524259:0.665495:0.906781:0.665495:0.906781:0.652172:0.524259:0.652172:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Jouppila P. the effects of ephedrine and etilefrine on :@0.554568:0.679724:0.906781:0.679724:0.906781:0.666401:0.554568:0.666401:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
uterine and fetal blood flow and on fetal myocardial :@0.554568:0.693953:0.906747:0.693953:0.906747:0.680629:0.554568:0.680629:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
function  during  spinal  anaesthesia  for  caesarean :@0.554568:0.708181:0.906764:0.708181:0.906764:0.694858:0.554568:0.694858:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
section. :@0.554568:0.722410:0.610910:0.722410:0.610910:0.709087:0.554568:0.709087:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
International Journal of Obstetric Anesthesia. :@0.611132:0.722410:0.906131:0.722410:0.906131:0.709322:0.611132:0.709322:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
1991;1(1):3-8.:@0.554568:0.736639:0.644434:0.736639:0.644434:0.723315:0.554568:0.723315:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
13.   Snyman Jr, ed.  vasocontrictors. :@0.524259:0.750867:0.782877:0.750867:0.782877:0.737544:0.524259:0.737544:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Monthly Index of :@0.787187:0.750867:0.906131:0.750867:0.906131:0.737779:0.787187:0.737779:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Medical Specialities.:@0.554568:0.765096:0.683090:0.765096:0.683090:0.752008:0.554568:0.752008:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 2011;51(2):149.:@0.683090:0.765096:0.788299:0.765096:0.788299:0.751773:0.683090:0.751773:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
14.   Holt  nF, Haspel Kl.  vasopressin:  a review of :@0.524259:0.779325:0.906815:0.779325:0.906815:0.766001:0.524259:0.766001:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
therapeutic applications. :@0.554568:0.793553:0.729785:0.793553:0.729785:0.780230:0.554568:0.780230:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Journal  of  Cardiothoracic :@0.733103:0.793553:0.906114:0.793553:0.906114:0.780465:0.733103:0.780465:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
and Vascular Anesthesia. :@0.554568:0.807782:0.718633:0.807782:0.718633:0.794694:0.554568:0.794694:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
2010;24(2):330-47.:@0.718633:0.807782:0.841887:0.807782:0.841887:0.794459:0.718633:0.794459:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
15.   de Kock M, laterre PF, andruetto P, vanderessen l, :@0.524259:0.822011:0.906798:0.822011:0.906798:0.808688:0.524259:0.808688:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
dekrom S,  vanderick  b, :@0.554568:0.836240:0.723730:0.836240:0.723730:0.822916:0.554568:0.822916:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
et  al.:@0.727408:0.836240:0.760641:0.836240:0.760641:0.823151:0.727408:0.823151:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
  ornipressin (Por 8): :@0.760641:0.836240:0.906815:0.836240:0.906815:0.822916:0.760641:0.822916:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
an efficient alternative to counteract hypotension :@0.554585:0.850468:0.906832:0.850468:0.906832:0.837145:0.554585:0.837145:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
during combined general/epidural anesthesia. :@0.554585:0.864697:0.906815:0.864697:0.906815:0.851374:0.554585:0.851374:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Anesthesia and Analgesia. :@0.554585:0.878926:0.727510:0.878926:0.727510:0.865838:0.554585:0.865838:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
2000;90(6):1301-7.:@0.727510:0.878926:0.850764:0.878926:0.850764:0.865602:0.727510:0.865602:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
16.   eriksson  bI, Quinlan  dJ,  eikelboom JW.  novel :@0.524276:0.893154:0.906798:0.893154:0.906798:0.879831:0.524276:0.879831:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
oral factor Xa and thrombin inhibitors  in the :@0.554585:0.907383:0.906849:0.907383:0.906849:0.894060:0.554585:0.894060:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
management of thromboembolism. :@0.554585:0.921612:0.838500:0.921612:0.838500:0.908289:0.554585:0.908289:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Annual :@0.855331:0.921612:0.906165:0.921612:0.906165:0.908524:0.855331:0.908524:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Reviews of Medicine. :@0.554585:0.935993:0.690052:0.935993:0.690052:0.922905:0.554585:0.922905:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
2011;62:41-57.:@0.690052:0.935993:0.787547:0.935993:0.787547:0.922670:0.690052:0.922670:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000